Westhoff Niklas, Rieger Constantin, Heidenreich Axel, Bolenz Christian, Michel Maurice Stephan
Klinik für Urologie und Urochirurgie, Universitätsmedizin Mannheim, Medizinische Fakultät Mannheim, Universität Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Deutschland.
Klinik für Urologie, Uro-Onkologie, roboter-assistierte und spezielle urologische Chirurgie, Uniklinik Köln, Köln, Deutschland.
Urologie. 2025 Jan;64(1):4-13. doi: 10.1007/s00120-024-02479-0. Epub 2024 Nov 26.
Urothelial carcinoma is one of the most common malignancies both in Germany and worldwide. Due to the frequent occurrence of late-onset or nonspecific symptoms, carcinomas are often diagnosed at advanced stages. Structured early detection programs have the potential to detect urothelial carcinoma in earlier stages and to improve survival rates. Various risk factors are associated with urothelial carcinoma, most notably tobacco abuse and occupational exposure, as well as genetic disorders such as Lynch syndrome in upper urinary tract carcinoma. In clinical practice, diagnostic tools include general examinations and ultrasound imaging of the urinary tract, with microhematuria and urine cytology playing key roles. For screening purposes noninvasive urine markers have demonstrated limited evidence. Despite the lack of optimal diagnostic markers for systematic early detection in high-risk populations, it is essential to ensure that every patient presenting with hematuria undergoes appropriate and risk-adapted diagnostics.
尿路上皮癌是德国和全球最常见的恶性肿瘤之一。由于晚期发病或非特异性症状频繁出现,尿路上皮癌往往在晚期才被诊断出来。结构化的早期检测项目有潜力在更早期阶段检测出尿路上皮癌,并提高生存率。多种风险因素与尿路上皮癌相关,最显著的是烟草滥用和职业暴露,以及上尿路癌中的林奇综合征等遗传疾病。在临床实践中,诊断工具包括全身检查和泌尿系统超声成像,其中微量血尿和尿液细胞学检查起着关键作用。对于筛查目的而言,非侵入性尿液标志物的证据有限。尽管缺乏用于高危人群系统早期检测的最佳诊断标志物,但确保每一位出现血尿的患者都接受适当且根据风险调整的诊断至关重要。